Your browser doesn't support javascript.
loading
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network.
Fukuma, Ryohei; Yanagisawa, Takufumi; Kinoshita, Manabu; Shinozaki, Takashi; Arita, Hideyuki; Kawaguchi, Atsushi; Takahashi, Masamichi; Narita, Yoshitaka; Terakawa, Yuzo; Tsuyuguchi, Naohiro; Okita, Yoshiko; Nonaka, Masahiro; Moriuchi, Shusuke; Takagaki, Masatoshi; Fujimoto, Yasunori; Fukai, Junya; Izumoto, Shuichi; Ishibashi, Kenichi; Nakajima, Yoshikazu; Shofuda, Tomoko; Kanematsu, Daisuke; Yoshioka, Ema; Kodama, Yoshinori; Mano, Masayuki; Mori, Kanji; Ichimura, Koichi; Kanemura, Yonehiro; Kishima, Haruhiko.
Afiliación
  • Fukuma R; Department of Neurosurgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Yanagisawa T; Department of Neuroinformatics, ATR Computational Neuroscience Laboratories, 2-2-2 Hikaridai, Seika-cho, Kyoto, 619-0288, Japan.
  • Kinoshita M; Department of Neurosurgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. tyanagisawa@nsurg.med.osaka-u.ac.jp.
  • Shinozaki T; Department of Neuroinformatics, ATR Computational Neuroscience Laboratories, 2-2-2 Hikaridai, Seika-cho, Kyoto, 619-0288, Japan. tyanagisawa@nsurg.med.osaka-u.ac.jp.
  • Arita H; Institute for Advanced Co-creation studies, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. tyanagisawa@nsurg.med.osaka-u.ac.jp.
  • Kawaguchi A; Department of Neurosurgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. mail@manabukinoshita.com.
  • Takahashi M; Center for Information and Neural Networks, National Institute of Information and Communications Technology, 1-4 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Narita Y; Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Terakawa Y; Department of Neurosurgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tsuyuguchi N; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
  • Okita Y; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.
  • Nonaka M; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, 849-8501, Japan.
  • Moriuchi S; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Takagaki M; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Fujimoto Y; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
  • Fukai J; Department of Neurosurgery, Osaka City General Hospital, Osaka, 534-0021, Japan.
  • Izumoto S; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
  • Ishibashi K; Department of Neurosurgery, Osaka City General Hospital, Osaka, 534-0021, Japan.
  • Nakajima Y; Department of Neurosurgery, Kindai University Faculty of Medicine, Sayama, 589-8511, Japan.
  • Shofuda T; Department of Neurosurgery, Osaka International Cancer Institute, Osaka Prefectural Hospital Organization, Osaka, 541-8567, Japan.
  • Kanematsu D; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
  • Yoshioka E; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan.
  • Kodama Y; Department of Neurosurgery, Kansai Medical University, Hirakata, 573-1191, Japan.
  • Mano M; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
  • Mori K; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan.
  • Ichimura K; Department of Neurosurgery, Rinku General Medical Center, Izumisano, 598-8577, Japan.
  • Kanemura Y; Department of Neurosurgery, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Kishima H; Kansai Molecular Diagnosis Network for CNS Tumors, Osaka, 540-0006, Japan.
Sci Rep ; 9(1): 20311, 2019 12 30.
Article en En | MEDLINE | ID: mdl-31889117
Identification of genotypes is crucial for treatment of glioma. Here, we developed a method to predict tumor genotypes using a pretrained convolutional neural network (CNN) from magnetic resonance (MR) images and compared the accuracy to that of a diagnosis based on conventional radiomic features and patient age. Multisite preoperative MR images of 164 patients with grade II/III glioma were grouped by IDH and TERT promoter (pTERT) mutations as follows: (1) IDH wild type, (2) IDH and pTERT co-mutations, (3) IDH mutant and pTERT wild type. We applied a CNN (AlexNet) to four types of MR sequence and obtained the CNN texture features to classify the groups with a linear support vector machine. The classification was also performed using conventional radiomic features and/or patient age. Using all features, we succeeded in classifying patients with an accuracy of 63.1%, which was significantly higher than the accuracy obtained from using either the radiomic features or patient age alone. In particular, prediction of the pTERT mutation was significantly improved by the CNN texture features. In conclusion, the pretrained CNN texture features capture the information of IDH and TERT genotypes in grade II/III gliomas better than the conventional radiomic features.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Regiones Promotoras Genéticas / Redes Neurales de la Computación / Telomerasa / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Regiones Promotoras Genéticas / Redes Neurales de la Computación / Telomerasa / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido